Evidence map›Paper›PMID 42415852›Full record

ReviewMedComm2026

The Multifaceted Role of Pyroptosis: Molecular Mechanisms, Crosstalk with Other Cell Death Pathways, and Therapeutic Implications.

Diego Liviu Boaru, Patricia De Castro-Martinez, Cielo Garcia-Montero, Oscar Fraile-Martinez, Majd N Michael Alhaddadin, Silvestra Barrena-Blázquez, Laura Lopez-Gonzalez, Clara Tasende Fernández, Ricardo Alvarado-Hurtado, Tomás Ratia Giménez and 9 more

Abstract readReview
In one paragraph

Review in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Diego Liviu BoaruDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Patricia De Castro-MartinezDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Cielo Garcia-MonteroDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Oscar Fraile-MartinezDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Majd N Michael AlhaddadinDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Silvestra Barrena-BlázquezRamón y Cajal Institute of Sanitary Research (IRYCIS) Madrid Spain.
Laura Lopez-GonzalezRamón y Cajal Institute of Sanitary Research (IRYCIS) Madrid Spain.
Clara Tasende FernándezEndocrinology and Nutrition Service Hospital Universitario Príncipe De Asturias (CIBEREHD) Alcalá de Henares Spain.
Ricardo Alvarado-HurtadoDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Tomás Ratia GiménezDepartment of Surgery Medical and Social Sciences Faculty of Medicine and Health Sciences University of Alcalá Alcalá de Henares Spain.
Inmaculada Lasa-UnzúeDepartment of Surgery Medical and Social Sciences Faculty of Medicine and Health Sciences University of Alcalá Alcalá de Henares Spain.
Manuel Díez AlonsoDepartment of Surgery Medical and Social Sciences Faculty of Medicine and Health Sciences University of Alcalá Alcalá de Henares Spain.
Alberto Gutiérrez-CalvoDepartment of Surgery Medical and Social Sciences Faculty of Medicine and Health Sciences University of Alcalá Alcalá de Henares Spain.
Miguel A SaezDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
David Cobo-PrietoDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Jose V SazDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Melchor Alvarez-MonDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.
Raul Diaz-PedreroRamón y Cajal Institute of Sanitary Research (IRYCIS) Madrid Spain.
Miguel A OrtegaDepartment of Medicine and Medical Specialties Faculty of Medicine and Health Sciences Network Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD) University of Alcalá Alcalá de Henares Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyroptosis is a tightly regulated, proinflammatory form of programmed cell death defined by gasdermin-mediated membrane pore formation and cytokine release. By coupling cell death to innate immune activation, pyroptosis occupies a unique position at the interface of host defense and tissue pathology. Recent advances have demonstrated that pyroptosis is activated through multiple molecular routes, including canonical and noncanonical inflammasome pathways, Caspase-3/8-gasdermin axes, and granzyme-dependent mechanisms. Importantly, pyroptosis does not operate in isolation but engages in extensive crosstalk with other programmed cell death modalities, such as apoptosis, necroptosis, ferroptosis, NETosis, and the integrative process of PANoptosis, sharing key regulators including caspases, inflammasomes, and gasdermins. Despite rapid progress, a unified framework integrating pyroptosis-specific mechanisms with interaction networks, temporal dynamics, and disease relevance is still lacking. In this review, we systematically dissect the molecular pathways governing pyroptosis, emphasize its functional interplay with other cell death programs, and discuss emerging concepts such as cell-type specificity and sublytic versus lytic outcomes. We further examine the contribution of pyroptosis to cancer, infectious, autoimmune, metabolic, and cardiovascular diseases, and critically evaluate therapeutic strategies aimed at either inhibiting excessive pyroptosis or exploiting it for immunogenic cell death. Collectively, this review offers a perspective-enhancing, mechanistic, and translational significance.

Indexed as

apoptosiscancerextracellular vesiclesnanoparticlesPANoptosispyroptosis

Identifiers

PMID42415852
PMCPMC13338712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.